287 related articles for article (PubMed ID: 25977335)
1. Targeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion.
Razidlo GL; Magnine C; Sletten AC; Hurley RM; Almada LL; Fernandez-Zapico ME; Ji B; McNiven MA
Cancer Res; 2015 Jul; 75(14):2907-15. PubMed ID: 25977335
[TBL] [Abstract][Full Text] [Related]
2. TGFβ promotes mesenchymal phenotype of pancreatic cancer cells, in part, through epigenetic activation of VAV1.
Huang PH; Lu PJ; Ding LY; Chu PC; Hsu WY; Chen CS; Tsao CC; Chen BH; Lee CT; Shan YS; Chen CS
Oncogene; 2017 Apr; 36(16):2202-2214. PubMed ID: 27893715
[TBL] [Abstract][Full Text] [Related]
3. Vav1 and mutant K-Ras synergize in the early development of pancreatic ductal adenocarcinoma in mice.
Salaymeh Y; Farago M; Sebban S; Shalom B; Pikarsky E; Katzav S
Life Sci Alliance; 2020 May; 3(5):. PubMed ID: 32277014
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model.
Tomioka D; Maehara N; Kuba K; Mizumoto K; Tanaka M; Matsumoto K; Nakamura T
Cancer Res; 2001 Oct; 61(20):7518-24. PubMed ID: 11606388
[TBL] [Abstract][Full Text] [Related]
5. Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin.
Rachagani S; Senapati S; Chakraborty S; Ponnusamy MP; Kumar S; Smith LM; Jain M; Batra SK
Br J Cancer; 2011 Mar; 104(6):1038-48. PubMed ID: 21364589
[TBL] [Abstract][Full Text] [Related]
6. Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis.
Fernandez-Zapico ME; Gonzalez-Paz NC; Weiss E; Savoy DN; Molina JR; Fonseca R; Smyrk TC; Chari ST; Urrutia R; Billadeau DD
Cancer Cell; 2005 Jan; 7(1):39-49. PubMed ID: 15652748
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH
Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764
[TBL] [Abstract][Full Text] [Related]
8. Vav1 as a central regulator of invadopodia assembly.
Razidlo GL; Schroeder B; Chen J; Billadeau DD; McNiven MA
Curr Biol; 2014 Jan; 24(1):86-93. PubMed ID: 24332539
[TBL] [Abstract][Full Text] [Related]
9. High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process.
Grassilli S; Brugnoli F; Lattanzio R; Rossi C; Perracchio L; Mottolese M; Marchisio M; Palomba M; Nika E; Natali PG; Piantelli M; Capitani S; Bertagnolo V
Oncotarget; 2014 Jun; 5(12):4320-36. PubMed ID: 24962430
[TBL] [Abstract][Full Text] [Related]
10. The haematopoietic specific signal transducer Vav1 is aberrantly expressed in lung cancer and plays a role in tumourigenesis.
Lazer G; Idelchuk Y; Schapira V; Pikarsky E; Katzav S
J Pathol; 2009 Sep; 219(1):25-34. PubMed ID: 19533802
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticles of VAV1 siRNA combined with LL37 peptide for the treatment of pancreatic cancer.
Agbaria M; Jbara-Agbaria D; Grad E; Ben-David-Naim M; Aizik G; Golomb G
J Control Release; 2023 Mar; 355():312-326. PubMed ID: 36736910
[TBL] [Abstract][Full Text] [Related]
12. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
Fujisawa T; Joshi B; Nakajima A; Puri RK
Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
[TBL] [Abstract][Full Text] [Related]
13. Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancreatic Cancer Metastasis through Targeting Myoferlin.
Li Y; He Y; Shao T; Pei H; Guo W; Mi D; Krimm I; Zhang Y; Wang P; Wang X; Liu M; Yi Z; Chen Y
J Med Chem; 2019 May; 62(10):4949-4966. PubMed ID: 31026162
[TBL] [Abstract][Full Text] [Related]
14. Leptin signaling enhances cell invasion and promotes the metastasis of human pancreatic cancer via increasing MMP-13 production.
Fan Y; Gan Y; Shen Y; Cai X; Song Y; Zhao F; Yao M; Gu J; Tu H
Oncotarget; 2015 Jun; 6(18):16120-34. PubMed ID: 25948792
[TBL] [Abstract][Full Text] [Related]
15. Effective targeted chemotherapy using AEZS-108 (AN-152) for LHRH receptor-positive pancreatic cancers.
Gründker C; Ernst J; Reutter MD; Ghadimi BM; Emons G
Oncol Rep; 2011 Sep; 26(3):629-35. PubMed ID: 21667032
[TBL] [Abstract][Full Text] [Related]
16. Vav1 downmodulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome.
Grassilli S; Brugnoli F; Lattanzio R; Marchisio M; Perracchio L; Piantelli M; Bavelloni A; Capitani S; Bertagnolo V
Mol Oncol; 2018 Jun; 12(7):1012-1025. PubMed ID: 29658179
[TBL] [Abstract][Full Text] [Related]
17. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
[TBL] [Abstract][Full Text] [Related]
18. The Trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma.
Miknyoczki SJ; Chang H; Klein-Szanto A; Dionne CA; Ruggeri BA
Clin Cancer Res; 1999 Aug; 5(8):2205-12. PubMed ID: 10473107
[TBL] [Abstract][Full Text] [Related]
19. Targeting the Vav1/miR‑29b axis as a potential approach for treating selected molecular subtypes of triple‑negative breast cancer.
Grassilli S; Vezzali F; Cairo S; Brugnoli F; Volinia S; De Mattei M; Judde JG; Bertagnolo V
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33846812
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of TGF-beta inhibitor is dependent on the microenvironment.
Medicherla S; Li L; Ma JY; Kapoun AM; Gaspar NJ; Liu YW; Mangadu R; O'Young G; Protter AA; Schreiner GF; Wong DH; Higgins LS
Anticancer Res; 2007; 27(6B):4149-57. PubMed ID: 18229422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]